Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3f10 | 8HG | 8-oxoguanine-DNA-glycosylase |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3f10 | 8HG | 8-oxoguanine-DNA-glycosylase | / | 1.000 | |
1bxk | NAD | dTDP-glucose 4,6-dehydratase 2 | / | 0.461 | |
2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
2zsb | ADP | Pantothenate kinase | 2.7.1.33 | 0.459 | |
3dy8 | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
2iyf | ERY | Oleandomycin glycosyltransferase | 2.4.1 | 0.456 | |
3qfr | FMN | NADPH--cytochrome P450 reductase | / | 0.456 | |
3wag | TYD | Glycosyltransferase | / | 0.456 | |
1nj6 | A5A | Proline--tRNA ligase | / | 0.454 | |
2hun | NAD | 336aa long hypothetical dTDP-glucose 4,6-dehydratase | / | 0.453 | |
2nr4 | FMN | Conserved protein | / | 0.453 | |
3fap | ARD | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.451 | |
3fap | ARD | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.451 | |
4dri | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.451 | |
4dri | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.451 | |
1nj5 | P5A | Proline--tRNA ligase | / | 0.450 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.449 | |
4bfs | ZVS | Pantothenate kinase | 2.7.1.33 | 0.449 | |
3gn7 | 3GN | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.448 | |
2oh0 | 2PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
3ens | ENS | Coagulation factor X | 3.4.21.6 | 0.447 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.446 | |
4y0k | NAP | AntE | / | 0.446 | |
1zap | A70 | Candidapepsin-2 | 3.4.23.24 | 0.445 | |
2fap | RAD | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.445 | |
2fap | RAD | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.445 | |
3br3 | ET | HTH-type transcriptional regulator QacR | / | 0.445 | |
4drh | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.445 | |
4drh | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.445 | |
1ja0 | FMN | NADPH--cytochrome P450 reductase | / | 0.444 | |
4mvc | CDC | Choline-phosphate cytidylyltransferase A | / | 0.444 | |
2bn4 | FMN | NADPH--cytochrome P450 reductase | / | 0.443 | |
2zsa | ADP | Pantothenate kinase | 2.7.1.33 | 0.443 | |
4c0b | ATP | mRNA cleavage and polyadenylation factor CLP1 | / | 0.443 | |
4djh | JDC | Kappa-type opioid receptor | / | 0.443 | |
1fap | RAP | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.442 | |
1fap | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.442 | |
2yy2 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3hl0 | NAD | Maleylacetate reductase | / | 0.442 | |
3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.442 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
1nsg | RAD | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.441 | |
1nsg | RAD | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.441 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 |